ABPA CLINICAL PRESENTATION AND FOLLOW UP-A CASE SERIES

ABPA (allergic bronchopulmonary aspergillosis) is immunologically mediated lung disease in response to aspergillus fumigatus1 in patients with asthma or cystic fibrosis2. A series of 5case reports of patients diagnosed with ABPA from 2022-2024 at Katuri medical college & hospital. The Clinical history mostly dominated by asthma & its exacerbations,radiological featuresmostly of bronchiectasis and mucus plugs and laboratory investigations were reviewed. This case series highlights the importance of early recognition of symptoms and early initiation of treatment®ular follow-up in order to prevent exacerbations.